This inventor holds 2 USPTO granted patents. Top assignees: Antios Therapeutics, Inc., Istituto Nazionale Genetica Molecolare - Ingm, Ospedale San Raffaele S.r.l.. Active years: 2022-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2022-2025
Title: The Innovative Journey of Romano Di Fabio
Introduction
Romano Di Fabio, a distinguished inventor based in Pomezia, Italy, has made remarkable contributions to the field of medical research. With a focus on tackling the hepatitis B virus (HBV), his work combines innovative thinking and scientific rigor.
Latest Patents
Di Fabio holds a significant patent for "Tricyclic inhibitors of Hepatitis B virus." This invention pertains to compounds that act as inhibitors of HBV. These compounds serve as a valuable asset in the treatment, prevention, and amelioration of HBV infections and their related conditions. The patent also includes pharmaceutical compositions that incorporate these compounds, showcasing their potential in the medical field.
Career Highlights
Di Fabio is currently associated with Antios Therapeutics, Inc., a company dedicated to developing innovative therapies for the treatment of viral infections. His dedication to research and development in this area has positioned him as a notable figure in the realm of pharmaceutical innovation.
Collaborations
Throughout his career, Di Fabio has collaborated with esteemed colleagues such as Raffaele De Francesco and Lorena Donnici. These partnerships have allowed for a dynamic exchange of ideas and expertise, further enhancing the scope and impact of his work.
Conclusion
Romano Di Fabio's contributions to hepatitis B research highlight the importance of innovation in medicine. Through his patent and collaborative efforts, he is paving the way for advancements that could significantly improve public health outcomes related to viral infections. His journey serves as an inspiration for future inventors and researchers in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile